Chutes & Ladders: Amwell’s ’25 loss, ’26 hopes; Teladoc’s flat 2025; Walgreens and Cigna layoffs; telehealth stable at 7%; Humana CenterWell buys MaxHealth clinics; Honest Health raises $140M ...
Their Q4 2025 revenue took a hit–$55.3 million was down 22.1% versus prior year, attributed to lower revenue from their Defense Health Agency (DHA) contract. It started with partner Leidos in 2023 but ...
There was no mention of a timetable for filing 2025 results. The preliminary 2025 results show flat revenue and a significant ...
For those who like to run the numbers, Danaher claims it is paying “18x estimated 2027 EBITDA, or 15x 2027 estimated EBITDA ...
The first paragraph has his story that he resigned from Masimo after the proxy loss, but a simple crosscheck would have ...
In terms of current dollars, 2025’s funding of $14.2 billion was, as projected, a snap back to 2020’s $14.4 billion, as 2024 was to 2019. In constant/inflation-adjusted dollars, applying a cumulative ...
Amazon’s clinic network, One Medical, premiers a ‘beta feature’ that analyzes personal lab results. The Health Insights feature, developed in partnership with Lifeforce, is on the Lab Results tab.
Teladoc formally responds to the Blue Orca Capital research report [TTA 25 Feb]. Their letter (PDF) via its legal counsel (King & Spalding) yesterday refutes Blue Orca’s allegations in a report on ...
Ardent has reported this to law enforcement and in their release, stated they are still determining the full impact of the event, though working with partners to restore access to electronic medical ...
One more funding. A competitor of Elon Musk’s Neuralink, Precision Neuroscience. closed their Series C at $102 million. This round was led by General Equity Holdings, with participation from firms ...
Hims & Hers expands to Ireland, France, and Germany, and adds to UK. Announced yesterday, the ambitious strategic acquisition of Zava, a similar online direct to consumer provider of telemedicine ...